Low-dose amphetamine medication, modulated as children grow, can benefit more children than not.

“What they said was look neuroplasticity is greatest in childhood and tapers off after about age 25. But neuroplasticity from age three until age 12 or 13 is exceedingly high. If you have the opportunity to work with a quality physician and treat these things early, these drugs can allow these frontal circuits, these task related circuits to achieve their appropriate levels of functioning and for kids to learn how to focus in a variety of different contexts.”